Table 3.

Unadjusted outcomes through last follow-up

	Nominal (n=1559)	AV adjusted (n=2294)	p value (vs. nominal)	VV adjusted (n=604)	p value (vs. nominal)	AV and VV adjusted (n=852)	p value (vs. nominal)
Follow-up, days	956 (328)	983 (322)	0.009	944 (344)	0.5	952 (330)	0.8
PCT activity	7 (4.2)	7.5 (4.6)	0.0005	6.9 (4.3)	0.8	7.3 (4.2)	0.2
Change from baseline	0.00 (1.4)	−0.03 (1.6)	0.5	−0.09 (1.5)	0.2	0.03 (1.5)	0.8
HRV SDANN	73.6 (20.7)	72.9 (18.8)	0.5	73 (21.4)	0.7	73.5 (22.4)	0.9
Change from baseline	0.83 (9.8)	0.92 (10.2)	0.9	0.21 (9.7)	0.5	0.71 (10.2)	0.9
HRV footprint	29 (8.9)	28.8 (9)	0.8	29.1 (10.5)	0.9	28.9 (9.6)	0.9
Change from baseline	0.24 (3.8)	0.14 (3.9)	0.7	0.63 (0.9)	0.3	−0.13 (4.5)	0.2
HRV mean HR	77 (8)	77.1 (8.2)	0.8	77.2 (10.2)	0.8	76.5 (9.5)	0.4
Change from baseline	−0.45 (3.4)	−0.47 (3.7)	0.9	−0.28 (4.4)	0.6	−0.08 (4.9)	0.2
AF burden >5 %	27.7 %	17.9 %	<0.0001	28.3 %	0.8	18.9 %	<0.0001
Change from baseline	4.00 % (21.0 %)	4.00 % (18.0 %)	0.8	3.00 % (19.0 %)	0.9	4.00 % (17.0 %)	0.6
Atrial pacing (%)	33 (37)	31 (35)	0.6	29 (36)	0.001	32 (37)	0.8
Change from baseline	1.00 (32)	4.00 (29)	0.03	2.00 (32)	0.9	5.00 (32)	0.06
LV pacing <95 %	17.3 %	17.8 %	0.6	19.2 %	0.3	18.5 %	0.4
Change from baseline	0.00 % (13.0 %)	−1.00 % (14.0 %)	0.8	−1.00 % (12.0 %)	0.046	−2.00 % (15.0 %)	0.09
ATP therapy	27.6 %	29.5 %	0.2	31.0 %	0.1	32.7 %	0.006
Shock during follow-up	13.1 %	13.4 %	0.8	12.9 %	0.9	16.7 %	0.01
Death	18.6 %	19.1 %	0.7	20.7 %	0.3	19.2 %	0.7

Numbers are % or mean (standard deviation)

AV atrioventricular timing, VV ventricular-to-ventricular timing, ATP anti-tachycardia pacing, AF atrial fibrillation, LV left ventricular, HRV heart rate variability, SDANN standard deviation of the average NN intervals, HR heart rate